# A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld Syringe

> **NCT01344863** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 119 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** trastuzumab [Herceptin]
- **DRUG:** trastuzumab [Herceptin]

## Key facts

- **NCT ID:** NCT01344863
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01344863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01344863, "A Study of Administration of Trastuzumab (Herceptin) by a Single-use Injection Device Versus a Handheld Syringe". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01344863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*